Integrative genomic analyses of the histamine H1 receptor and its role in cancer prediction

International Journal of Molecular Medicine

Volumn 33, Issue 4, 2014, Pages 1019-1026

  Wang, Minghai ^a   Wei, Xiaolong ^b   Shi, Lianghui ^a   Chen, Bin ^a   Zhao, Guohai ^a   Yang, Haiwei ^c  

^a WANNAN MEDICAL COLLEGE   (China)

^b CANCER HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cancer; Comparative genomics; HRH1; Meta analysis; Prognosis

Indexed keywords

HISTAMINE H1 RECEPTOR;

ADIPOCYTE; ALLELE; ARTICLE; BIRD; BLADDER CANCER; BLOOD; BONE MARROW; BRAIN; BRAIN CANCER; BREAST CANCER; CANCER PROGNOSIS; CEREBELLUM; COLON; COLORECTAL CANCER; DATA BASE; EYE CANCER; FISH; GENE EXPRESSION; GENOME ANALYSIS; HEAD AND NECK CANCER; HEART; HUMAN; KIDNEY; LIVER; LUNG; LUNG CANCER; LYMPH NODE; MAMMAL; MISSENSE MUTATION; NEOPLASM; NONHUMAN; ONCOGENE C MYB; OVARY; OVARY CANCER; PANCREAS; PLACENTA; PRIORITY JOURNAL; PROSTATE; PROTEIN EXPRESSION; RETINA; SALIVARY GLAND; SINGLE NUCLEOTIDE POLYMORPHISM; SKELETAL MUSCLE; SKIN; SKIN CANCER; SMALL INTESTINE; SMOOTH MUSCLE; SOFT TISSUE CANCER; SPINAL CORD; TESTIS; THYMUS; THYROID GLAND; UTERUS;

ANIMALS; DATABASES, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME; GENOMICS; HUMANS; META-ANALYSIS AS TOPIC; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHYLOGENY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROTEOMICS; RECEPTORS, HISTAMINE H1; VERTEBRATES;

EID: 84899535884     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1649     Document Type: Article

References (58)

1. Seifert R, Strasser A, Schneider EH, Neumann D, Dove S and Buschauer A: Molecular and cellular analysis of human histamine receptor subtypes. Trends Pharmacol Sci 34: 33-58, 2013.
2. Yoshizawa M, Tashiro M, Fukudo S, et al: Increased brain histamine H1 receptor binding in patients with anorexia nervosa. Biol Psychiatry 65: 329-335, 2009.
3. Booth RG, Fang L, Wilczynski A, et al: Molecular determinants of ligand-directed signaling for the histamine H1 receptor. Inflamm Res 57 (Suppl 1): S43-S44, 2008.
4. Swan C, Richards SA, Duroudier NP, Sayers I and Hall IP: Alternative promoter use and splice variation in the human histamine H1 receptor gene. Am J Respir Cell Mol Biol 35: 118-226, 2006.
5. Oda T, Morikawa N, Saito Y, Masuho Y and Matsumoto S: Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 275: 36781-36788, 2000.
6. Breunig E, Michel K, Zeller F, Seidl S, Weyhern CW and Schemann M: Histamine excites neurones in the human submucous plexus through activation of H1, H2, H3 and H4 receptors: J Physiol 583: 731-742, 2007.
7. Brew OB and Sullivan MH: Localisation of mRNAs for diamine oxidase and histamine receptors H1 and H2, at the feto-maternal interface of human pregnancy. Inflamm Res 50: 449-452, 2001.
8. Arisawa T, Tahara T, Ozaki K, et al: Association between common genetic variant of HRH2 and gastric cancer risk. Int J Oncol 41: 497-503, 2012.
9. Lefranc F, Yeaton P, Brotchi J and Kiss R: Cimetidine, an unexpected anti-tumor agent, and its potential for the treatment of glioblastoma. Int J Oncol 28: 1021-1030, 2006.
10. Davio C, Baldi A, Mladovan A, Cricco G, Fitzsimons C and Bergoc RR: Expression of histamine receptors in different cell lines derived from mammary gland and human breast carcinomas. Inflamm Res 44 (Suppl 1): S70-S71, 1995.
11. Jiang CG, Liu FR, Yu M, Li JB and Xu HM: Cimetidine induces apoptosis in gastric cancer cells in vitro and inhibits tumor growth in vivo. Oncol Rep 23: 693-700, 2010.
12. Fukuda M, Tanaka S, Suzuki S, Kusama K, Kaneko T and Sakashita H: Cimetidine induces apoptosis of human salivary gland tumor cells. Oncol Rep 17: 673-678, 2007.
13. Yang L, Luo Y and Wei J: Integrative genomic analyses on Ikaros and its expression related to solid cancer prognosis. Oncol Rep 24: 571-577. 2010.
14. Yang L, Luo Y, Wei J and He S: Integrative genomic analyses on IL28RA, the common receptor of interferon-λ1, -λ2 and -λ3. Int J Mol Med 25: 807-812. 2010.
15. Yang L, Wei J and He S: Integrative genomic analyses on interferon-λs and their roles in cancer prediction. Int J Mol Med 25: 299-304. 2010.
16. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F and Higgins DG: The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 15: 4876-4882, 1997.
17. Guindon S, Lethiec F, Duroux P and Gascuel O: PHYML Online - a web server for fast maximum likelihood-based phylogenetic inference. Nucleic Acids Res 33: W557-W559, 2005.
18. Kumar S, Tamura K and Nei M: MEGA3: Integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 5: 150-163, 2004.
19. Yang Z: PAML: a program package for phylogenetic analysis by maximum likelihood. Comput Appl Biosci 13: 555-556, 1997.
20. Yang Z, Nielsen R, Goldman N and Pedersen AM: Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics 155: 431-449, 2000.
21. Yu H, Yuan J, Xiao C and Qin Y: Integrative genomic analyses of recepteur d'origine nantais and its prognostic value in cancer. Int J Mol Med 31: 1248-1254, 2013.
22. Katoh Y and Katoh M: Integrative genomic analyses on GLI1: positive regulation of GLI1 by Hedgehog-GLI, TGFβ-Smads, and RTK-PI3K-AKT signals, and negative regulation of GLI1 by Notch-CSL-HES/HEY, and GPCR-Gs-PKA signals. Int J Oncol 35: 187-192, 2009.
23. Katoh M and Katoh M: Integrative genomic analyses of WNT11: transcriptional mechanisms based on canonical WNT signals and GATA transcription factors signaling. Int J Mol Med 24: 247-251, 2009.
24. Katoh M and Katoh M: Transcriptional mechanisms of WNT5A based on NF-κB, Hedgehog, TGFβ, and Notch signaling cascades. Int J Mol Med 23: 763-769, 2009.
25. Katoh M and Katoh M: Integrative genomic analyses of ZEB2: Transcriptional regulation of ZEB2 based on SMADs, ETS1, HIF1α, POU/OCT, and NF-κB. Int J Oncol 34: 1737-1742, 2009.
26. Chalifa-Caspi V, Yanai I, Ophir R, et al: GeneAnnot: comprehensive two-way linking between oligonucleotide array probesets and GeneCards genes. Bioinformatics 20: 1457-1458, 2004.
27. Parkinson H, Sarkans U, Shojatalab M, et al: ArrayExpress - a public repository for microarray gene expression data at the EBI. Nucleic Acids Res 33: D553-D555, 2005.
28. Kolker E, Higdon R, Morgan P, et al: SPIRE: Systematic protein investigative research environment. J Proteomics 75: 122-126, 2011.
29. Kolker E, Higdon R, Haynes W, et al: MOPED: Model Organism Protein Expression Database. Nucleic Acids Res 40: D1093-D1099, 2012.
30. Mizuno H, Kitada K, Nakai K and Sarai A: PrognoScan: a new database for meta-analysis of the prognostic value of genes. BMC Med Genomics 2: 18, 2009.
31. Xu TR, Yang Y, Ward R, Gao L and Liu Y: Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders. Cell Signal 25: 2413-2423, 2013.
32. Medina VA and Rivera ES: Histamine receptors and cancer pharmacology. Br J Pharmacol 61: 755-767, 2010.
33. Blaya B, Nicolau-Galmés F, Jangi SM, et al: Histamine and histamine receptor antagonists in cancer biology. Inflamm Allergy Drug Targets 9: 146-157, 2010.
34. Schlossmacher G, Stevens A and White A: Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells. J Endocrinol 211: 17-25, 2011.
35. Feng Y, Bai X, Yang Q, Wu H and Wang D: Downregulation of 15-lipoxygenase 2 by glucocorticoid receptor in prostate cancer cells. Int J Oncol 36: 1541-1549, 2010.
36. Jang JH, Woo SM, Um HJ, et al: RU486, a glucocorticoid receptor antagonist, induces apoptosis in U937 human lymphoma cells through reduction in mitochondrial membrane potential and activation of p38 MAPK. Oncol Rep 30: 506-512, 2013.
37. Koptyra M, Gupta S, Talati P and Nevalainen MT: Signal transducer and activator of transcription 5a/b: biomarker and therapeutic target in prostate and breast cancer. Int J Biochem Cell Biol 43: 1417-1421, 2011.
38. Hou L, Xu B, Mohankumar KM, Goffin V, Perry JK, Lobie PE and Liu DX: The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells. Int J Oncol 41: 2285-2295, 2012.
39. Haeri M, Li Y, Li Y, Li Q, Spaner DE and Ben-David Y: Insertional activation of myb by F-MuLV in SCID mice induces myeloid leukemia. Int J Oncol 43: 169-176, 2013.
40. Zhang J, Luo N, Luo Y, Peng Z, Zhang T and Li S: microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb. Int J Oncol 40: 747-756, 2012.
41. Kim WJ, Kim EJ, Kim SK, et al: Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer. Mol Cancer 9: 3, 2010.
42. Lee JS, Leem SH, Lee SY, et al: Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors. J Clin Oncol 28: 2660-2667, 2010.
43. Hummel M, Bentink S, Berger H, et al: Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 354: 2419-2430, 2006.
44. Zhan F, Huang Y, Colla S, et al: The molecular classification of multiple myeloma. Blood 108: 2020-2028, 2006.
45. Phillips HS, Kharbanda S, Chen R, et al: Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9: 157-173, 2006.
46. Bos PD, Zhang XH, Nadal C, et al: Genes that mediate breast cancer metastasis to the brain. Nature 459: 1005-1009, 2009.
47. Loi S, Haibe-Kains B, Majjaj S, et al: PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer. Proc Natl Acad Sci USA 107: 10208-10213, 2010.
48. Chanrion M, Negre V, Fontaine H, et al: A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer. Clin Cancer Res 14: 1744-1752, 2008.
49. Pawitan Y, Bjöhle J, Amler L, et al: Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res 7: R953-R964, 2005.
50. Miller LD, Smeds J, George J, et al: An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci USA 102: 13550-13555, 2005.
51. Smith JJ, Deane NG, Wu F, et al: Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology 138: 958-968, 2010.
52. Laurent C, Valet F, Planque N, et al: High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients. Cancer Res 71: 666-674, 2011.
53. Director's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma, Shedden K, Taylor JM, et al: Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med 14: 822-827, 2008.
54. Tomida S, Takeuchi T, Shimada Y, et al: Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis. J Clin Oncol 27: 2793-2799, 2009.
55. Okayama H, Kohno T, Ishii Y, et al: Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res 72: 100-111, 2012.
56. Lee ES, Son DS, Kim SH, et al: Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression. Clin Cancer Res 14: 7397-7404, 2008.
57. Yoshihara K, Tajima A, Yahata T, et al: Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets. PLoS One 5: e9615, 2010.
58. Gobble RM, Qin LX, Brill ER, et al: Expression profiling of liposarcoma yields a multigene predictor of patient outcome and identifies genes that contribute to liposarcomagenesis. Cancer Res 71: 2697-2705, 2011.